Related Experiment Video
Updated: Jan 29, 2026

Robotic Ablation of Atrial Fibrillation
Published on: May 29, 2015
Diagnostic Performance of a DOAC Urine Dipstick in Obese Outpatients with Atrial Fibrillation: Comparison with Plasma
Arianna Pannunzio1,2, Valentina Castellani3, Erminia Baldacci3
1Department of General Surgery, Surgical Specialty and Anaesthesiology, Sapienza University of Rome, 00185 Rome, Italy.
Insights
A new urine point-of-care test for direct oral anticoagulants (DOACs) shows high sensitivity but low specificity in obese atrial fibrillation (AF) patients. This diagnostic tool may only be useful in specific clinical situations for managing anticoagulation.
Area of Science:
- Cardiology
- Pharmacology
- Clinical Diagnostics
Background:
- Obese patients with atrial fibrillation (AF) require oral anticoagulant therapy due to high thromboembolic risk.
- Limited data exist on direct oral anticoagulants (DOACs) in this specific patient group.
- A validated point-of-care (POC) method is needed for rapid clinical decisions and to establish plasma concentration thresholds.
Purpose of the Study:
- To evaluate the diagnostic accuracy of a urinary DOACs Dipstick test compared to plasma concentrations in obese AF outpatients.
- To determine the sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of the POC test.
- To perform sub-analyses based on obesity severity and DOAC type.
Main Methods:
- A monocentric, cross-sectional diagnostic accuracy study involving 160 obese AF outpatients.
- Paired urine and plasma samples were collected.
- Urinary Dipsticks (for Factor Xa inhibitors and thrombin inhibitors) were compared against reference standard plasma concentrations (trough and peak) using chromogenic assays/dTT.
Main Results:
- The DOACs Dipstick demonstrated high sensitivity (99.24% vs. trough, 97.8% vs. peak) but low specificity (6.89% vs. trough, 0% vs. peak) when compared to plasma concentrations.
- Compared to plasma thresholds > 30 ng/mL, the test showed 99.10% sensitivity and 4.70% specificity.
- Positive predictive values were acceptable (82.80% vs. trough, 85.9% vs. peak), but negative predictive values were low (66.67% vs. trough, not provided vs. peak).
Conclusions:
- The urine POC test exhibits high sensitivity and acceptable PPV in obese AF patients.
- However, the test's low specificity and NPV limit its broad clinical utility.
- The DOACs Dipstick may be valuable only in selected clinical scenarios for managing anticoagulation in this population.
Abstract:
Background: atrial fibrillation (AF) patients with obesity and high thromboembolic risk need oral anticoagulant therapy. Limited data are available on direct oral anticoagulants (DOACs) in this population, and a point-of-care method has been validated to support rapid clinical decisions and to identify on-off plasma concentration thresholds. Methods: This is a monocentric, cross-sectional diagnostic accuracy study on obese AF outpatients referred to Policlinico Umberto I of Rome. Urinary Dipsticks were assessed with separate pads for factor Xa (FXA-i) and thrombin inhibitor (THR-i) and compared to the reference standard of trough and peak plasma concentrations with chromogenic assays/dTT and prespecified plasma thresholds for each DOAC. Study endpoints were the sensitivity, specificity, positive and negative predictive values (PPV and NPV) of DOACs Dipstick compared to plasma concentrations. Sub-analyses according to obesity severity and type of DOAC were performed. Results: 320 paired plasma and urine samples were available from 160 enrolled patients (mean age 73.2 ± 9.1 years). Compared to trough plasma concentrations, DOACs Dipstick showed a sensitivity of 99.24% (mean, 95% confidence interval, CI 95.82-99.98), specificity of 6.89% (0.85-22.76), PPV 82.80% (81.32-84.18), NPV 66.67% (15.79-95.52). On the other hand, compared to peak plasma concentrations, DOACs Dipstick showed a sensitivity of 97.8% (93.7-99.5), specificity of 0% (0.0-15.4), and PPV of 85.9% (85.6-86.2). Urinary Dipstick showed a sensitivity of 99.10% (95.4-100.0), specificity of 4.70% (0.60-16.20) and a PPV and NPV of 74.50% (73.2-75.8) and 66.70 (15.7-95.6), compared to plasma thresholds > 30 ng/mL of FXA-I and THR-I. Sub-analyses showed similar results between FXA-i and THR-i. Conclusions: The urine point-of-care has high sensitivity, acceptable PPV, but low specificity and NPV in AF obese patients and may be useful only in selected clinical scenarios.
Related Concept Videos
Formation of Concentrated Urine
Physiology of the Genitourinary System III: Urine Concentration and Dilution
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Filtration and Urine Formation
Obesity

